Gout: A review of nonmodifiable and modifiable risk factors

Rheumatic Disease Clinics of North America

Volumn 40, Issue 4, 2014, Pages 581-604

  MacFarlane, Lindsey A ^a   Kim, Seoyoung C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Diet; Genetics; Gout; Race; Risk factors; Sex

Indexed keywords

ALCOHOL; ASCORBIC ACID; BREAST CANCER RESISTANCE PROTEIN; FRUCTOSE; URATE TRANSPORTER; URIC ACID;

AGE; COFFEE; CRYSTALLIZATION; DAIRY PRODUCT; DIET; DISEASE PREDISPOSITION; ETHNICITY; GENDER; GENETIC RISK; GENETICS; GOUT; HEREDITY; HUMAN; INFLAMMATORY DISEASE; JOINT; LIFESTYLE; NONHUMAN; PATHOGENESIS; PREVALENCE; RACE; REVIEW; RISK FACTOR; SOFT DRINK; FEMALE; GENETIC PREDISPOSITION; HYPERURICEMIA; MALE; OBESITY; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA;

AGE FACTORS; DIET; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GOUT; HUMANS; HYPERURICEMIA; MALE; OBESITY; RISK FACTORS; SEX FACTORS;

EID: 84908071680     PISSN: 0889857X     EISSN: 15583163     Source Type: Journal    
DOI: 10.1016/j.rdc.2014.07.002     Document Type: Review

References (146)

1. Lipkowitz M.S. Regulation of uric acid excretion by the kidney. Curr Rheumatol Rep 2012, 14(2):179-188.
2. Roddy E., Choi H.K. Epidemiology of Gout. Rheum Dis Clin North Am 2014, 40(2):155-175.
3. Campion E.W., Glynn R.J., DeLabry L.O. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987, 82(3):421-426.
4. Bhole V., de Vera M., Rahman M.M., et al. Epidemiology of gout in women: fifty-two-year followup of a prospective cohort. Arthritis Rheum 2010, 62(4):1069-1076.
5. Zhu Y., Pandya B.J., Choi H.K. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011, 63(10):3136-3141.
6. Wertheimer A., Morlock R., Becker M.A. Arevised estimate of the burden of illness of gout. Curr Ther Res Clin Exp 2013, 75:1-4.
7. Singh J.A., Reddy S.G., Kundukulam J. Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol 2011, 23(2):192-202.
8. Wallace K.L., Riedel A.A., Joseph-Ridge N., et al. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. JRheumatol 2004, 31(8):1582-1587.
9. Maynard J.W., McAdams-Demarco M.A., Law A., et al. Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities Study. Am J Epidemiol 2014, 179(5):576-583.
10. Reginato A.M., Mount D.B., Yang I., et al. The genetics of hyperuricaemia and gout. Nat Rev Rheumatol 2012, 8(10):610-621.
11. Merriman T.R., Choi H.K., Dalbeth N. The genetic basis of gout. Rheum Dis Clin North Am 2014, 40(2):279-290.
12. Choi H.K., Mount D.B., Reginato A.M. Pathogenesis of gout. Ann Intern Med 2005, 143(7):499-516.
13. Öztürk M.A., Kaya A., Senel S., et al. Demographic and clinical features of gout patients in Turkey: a multicenter study. Rheumatol Int 2013, 33(4):847-852.
14. Chen J.H., Yeh W.T., Chuang S.Y., et al. Gender-specific risk factors for incident gout: a prospective cohort study. Clin Rheumatol 2012, 31(2):239-245.
15. Puig J.G., Michan A.D., Jimenez M.L., et al. Female gout. Clinical spectrum and uric acid metabolism. Arch Intern Med 1991, 151(4):726-732.
16. Hak A.E., Choi H.K. Menopause, postmenopausal hormone use and serum uric acid levels in US women-the Third National Health and Nutrition Examination Survey. Arthritis Res Ther 2008, 10(5):R116.
17. Hak A.E., Curhan G.C., Grodstein F., et al. Menopause, postmenopausal hormone use and risk of incident gout. Ann Rheum Dis 2010, 69(7):1305-1309.
18. Takiue Y., Hosoyamada M., Kimura M., et al. The effect of female hormones upon urate transport systems in the mouse kidney. Nucleosides Nucleotides Nucleic Acids 2011, 30(2):113-119.
19. Choi H.K., Ford E.S. Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels-the Third National Health and Nutrition Examination Survey. Rheumatology (Oxford) 2008, 47(5):713-717.
20. Fang J., Alderman M.H. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000, 283(18):2404-2410.
21. Saag K.G., Choi H. Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther 2006, 8(Suppl 1):S2.
22. Kuzuya M., Ando F., Iguchi A., et al. Effect of aging on serum uric acid levels: longitudinal changes in a large Japanese population group. JGerontol A Biol Sci Med Sci 2002, 57(10):M660-M664.
23. Hochberg M.C., Thomas J., Thomas D.J., et al. Racial differences in the incidence of gout. The role of hypertension. Arthritis Rheum 1995, 38(5):628-632.
24. Gaffo A.L., Jacobs D.R., Lewis C.E., et al. Association between being African-American, serum urate levels and the risk of developing hyperuricemia: findings from the Coronary Artery Risk Development in Young Adults cohort. Arthritis Res Ther 2012, 14(1):R4.
25. DeBoer M.D., Dong L., Gurka M.J. Racial/ethnic and sex differences in the relationship between uric acid and metabolic syndrome in adolescents: an analysis of National Health and Nutrition Survey 1999-2006. Metabolism 2012, 61(4):554-561.
26. Klemp P., Stansfield S.A., Castle B., et al. Gout is on the increase in New Zealand. Ann Rheum Dis 1997, 56(1):22-26.
27. Rose B.S. Gout in Maoris. Semin Arthritis Rheum 1975, 5(2):121-145.
28. Singh J.A. Racial and gender disparities among patients with gout. Curr Rheumatol Rep 2013, 15(2):307.
29. Winnard D., Wright C., Taylor W.J., et al. National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology (Oxford) 2012, 51(5):901-909.
30. Stamp L.K., Wells J.E., Pitama S., et al. Hyperuricaemia and gout in New Zealand rural and urban Maori and non-Maori communities. Intern Med J 2013, 43(6):678-684.
31. Portis A.J., Laliberte M., Tatman P., et al. High prevalence of gouty arthritis among the Hmong population in Minnesota. Arthritis Care Res (Hoboken) 2010, 62(10):1386-1391.
32. Wahedduddin S., Singh J.A., Culhane-Pera K.A., et al. Gout in the Hmong in the United States. JClin Rheumatol 2010, 16(6):262-266.
33. Prasad P., Krishnan E. Filipino gout: a review. Arthritis Care Res (Hoboken) 2014, 66(3):337-343.
34. Emmerson B.T., Nagel S.L., Duffy D.L., et al. Genetic control of the renal clearance of urate: a study of twins. Ann Rheum Dis 1992, 51(3):375-377.
35. Wilk J.B., Djousse L., Borecki I., et al. Segregation analysis of serum uric acid in the NHLBI Family Heart Study. Hum Genet 2000, 106(3):355-359.
36. Yang Q., Guo C.Y., Cupples L.A., et al. Genome-wide search for genes affecting serum uric acid levels: the Framingham Heart Study. Metabolism 2005, 54(11):1435-1441.
37. Enomoto A., Kimura H., Chairoungdua A., et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002, 417(6887):447-452.
38. Taniguchi A., Urano W., Yamanaka M., et al. Acommon mutation in an organic anion transporter gene, SLC22A12, is a suppressing factor for the development of gout. Arthritis Rheum 2005, 52(8):2576-2577.
39. Iwai N., Mino Y., Hosoyamada M., et al. Ahigh prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese. Kidney Int 2004, 66(3):935-944.
40. Graessler J., Graessler A., Unger S., et al. Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum 2006, 54(1):292-300.
41. Li C., Han L., Levin A.M., et al. Multiple single nucleotide polymorphisms in the human urate transporter 1 (hURAT1) gene are associated with hyperuricaemia in Han Chinese. JMed Genet 2010, 47(3):204-210.
42. Vazquez-Mellado J., Jimenez-Vaca A.L., Cuevas-Covarrubias S., et al. Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology (Oxford) 2007, 46(2):215-219.
43. Caulfield M.J., Munroe P.B., O'Neill D., et al. SLC2A9 is a high-capacity urate transporter in humans. PLoS Med 2008, l(10):e197.
44. Anzai N., Ichida K., Jutabha P., et al. Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. JBiol Chem 2008, 283(40):26834-26838.
45. Vitart V., Rudan I., Hayward C., et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 2008, 40(4):437-442.
46. Matsuo H., Chiba T., Nagamori S., et al. Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am J Hum Genet 2008, 83(6):744-751.
47. Doring A., Gieger C., Mehta D., et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 2008, 40(4):430-436.
48. Wallace C., Newhouse S.J., Braund P., et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 2008, 82(1):139-149.
49. Kolz M., Johnson T., Sanna S., et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 2009, 5(6):e1000504.
50. Karns R., Zhang G., Sun G., et al. Genome-wide association of serum uric acid concentration: replication of sequence variants in an island population of the Adriatic coast of Croatia. Ann Hum Genet 2012, 76(2):121-127.
51. Brandstatter A., Kiechl S., Kollerits B., et al. Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI. Diabetes Care 2008, 31(8):1662-1667.
52. Hollis-Moffatt J.E., Gow P.J., Harrison A.A., et al. The SLC2A9 nonsynonymous Arg265His variant and gout: evidence for a population-specific effect on severity. Arthritis Res Ther 2011, 13(3):R85.
53. Mobasheri A., Neama G., Bell S., et al. Human articular chondrocytes express three facilitative glucose transporter isoforms: GLUT1, GLUT3 and GLUT9. Cell Biol Int 2002, 26(3):297-300.
54. Woodward O.M., Kottgen A., Coresh J., et al. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci USA 2009, 106(25):10338-10342.
55. Dehghan A., Kottgen A., Yang Q., et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 2008, 372(9654):1953-1961.
56. Matsuo H., Takada T., Ichida K., et al. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med 2009, 1(5):5ra11.
57. Matsuo H., Ichida K., Takada T., et al. Common dysfunctional variants in ABCG2 are a major cause of early-onset gout. Sci Rep 2013, 3:2014.
58. Tu H.P., Ko A.M., Chiang S.L., et al. Joint effects of alcohol consumption and ABCG2 Q141K on chronic tophaceous gout risk. JRheumatol 2014, 41(4):749-758.
59. Tin A., Woodward O.M., Kao W.H., et al. Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele. Hum Mol Genet 2011, 20(20):4056-4068.
60. Kottgen A., Albrecht E., Teumer A., et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet 2013, 45(2):145-154.
61. Maclachlan M.J., Rodnan G.P. Effect of food, fast and alcohol on serum uric acid and acute attacks of gout. Am J Med 1967, 42(1):38-57.
62. Faller J., Fox I.H. Ethanol-induced hyperuricemia: evidence for increased urate production by activation of adenine nucleotide turnover. NEngl J Med 1982, 307(26):1598-1602.
63. Faller J., Fox I.H. Ethanol induced alterations of uric acid metabolism. Adv Exp Med Biol 1984, 165(Pt A):457-462.
64. Moriwaki Y., Ka T., Takahashi S., et al. Effect of beer ingestion on the plasma concentrations and urinary excretion of purine bases: one-month study. Nucleosides Nucleotides Nucleic Acids 2006, 25(9-11):1083-1085.
65. Ka T., Moriwaki Y., Takahashi S., et al. Effects of long-term beer ingestion on plasma concentrations and urinary excretion of purine bases. Horm Metab Res 2005, 37(10):641-645.
66. Gibson T., Rodgers A.V., Simmonds H.A., et al. Beer drinking and its effect on uric acid. Br J Rheumatol 1984, 23(3):203-209.
67. Yamamoto T., Moriwaki Y., Takahashi S., et al. Effect of beer on the plasma concentrations of uridine and purine bases. Metabolism 2002, 51(10):1317-1323.
68. Choi H.K., Curhan G. Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2004, 51(6):1023-1029.
69. Gaffo A.L., Roseman J.M., Jacobs D.R., et al. Serum urate and its relationship with alcoholic beverage intake in men and women: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) cohort. Ann Rheum Dis 2010, 69(11):1965-1970.
70. Choi H.K., Atkinson K., Karlson E.W., et al. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004, 363(9417):1277-1281.
71. Dalvi S.R., Pillinger M.H. Saturnine gout, redux: a review. Am J Med 2013, 126(5):450.e1-450.e8.
72. Krishnan E., Lingala B., Bhalla V. Low-level lead exposure and the prevalence of gout: an observational study. Ann Intern Med 2012, 157(4):233-241.
73. Wang M., Jiang X., Wu W., et al. Ameta-analysis of alcohol consumption and the risk of gout. Clin Rheumatol 2013, 32(11):1641-1648.
74. Matzkies F., Berg G., Madl H. The uricosuric action of protein in man. Adv Exp Med Biol 1980, 122A:227-231.
75. Choi H.K., Liu S., Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2005, 52(1):283-289.
76. Choi H.K., Atkinson K., Karlson E.W., et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. NEngl J Med 2004, 350(11):1093-1103.
77. Villegas R., Xiang Y.B., Elasy T., et al. Purine-rich foods, protein intake, and the prevalence of hyperuricemia: the Shanghai Men's Health Study. Nutr Metab Cardiovasc Dis 2012, 22(5):409-416.
78. Yu K.H., See L.C., Huang Y.C., et al. Dietary factors associated with hyperuricemia in adults. Semin Arthritis Rheum 2008, 37(4):243-250.
79. Messina M., Messina V.L., Chan P. Soyfoods, hyperuricemia and gout: a review of the epidemiologic and clinical data. Asia Pac J Clin Nutr 2011, 20(3):347-358.
80. Choi H.K. Aprescription for lifestyle change in patients with hyperuricemia and gout. Curr Opin Rheumatol 2010, 22(2):165-172.
81. Fox I.H., Kelley W.N. Studies on the mechanism of fructose-induced hyperuricemia in man. Metabolism 1972, 21(8):713-721.
82. Raivio K.O., Becker A., Meyer L.J., et al. Stimulation of human purine synthesis de novo by fructose infusion. Metabolism 1975, 24(7):861-869.
83. Emmerson B.T. Effect of oral fructose on urate production. Ann Rheum Dis 1974, 33(3):276-280.
84. Choi J.W., Ford E.S., Gao X., et al. Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2008, 59(1):109-116.
85. Choi H.K., Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 2008, 336(7639):309-312.
86. Choi H.K., Willett W., Curhan G. Fructose-rich beverages and risk of gout in women. JAMA 2010, 304(20):2270-2278.
87. Dalbeth N., House M.E., Gamble G.D., et al. Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load. Ann Rheum Dis 2013, 72(11):1868-1873.
88. Dalbeth N., House M.E., Gamble G.D., et al. Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge. Arthritis Res Ther 2014, 16(1):R34.
89. Batt C., Phipps-Green A.J., Black M.A., et al. Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout. Ann Rheum Dis 2013, [Epub ahead of print].
90. Jeroncic I., Mulic R., Klismanic Z., et al. Interactions between genetic variants in glucose transporter type 9 (SLC2A9) and dietary habits in serum uric acid regulation. Croat Med J 2010, 51(1):40-47.
91. Gao X., Qi L., Qiao N., et al. Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women. Hypertension 2007, 50(2):306-312.
92. Wang D.D., Sievenpiper J.L., de Souza R.J., et al. The effects of fructose intake on serum uric acid vary among controlled dietary trials. JNutr 2012, 142(5):916-923.
93. Sun S.Z., Flickinger B.D., Williamson-Hughes P.S., et al. Lack of association between dietary fructose and hyperuricemia risk in adults. Nutr Metab (Lond) 2010, 7:16.
94. Zgaga L., Theodoratou E., Kyle J., et al. The association of dietary intake of purine-rich vegetables, sugar-sweetened beverages and dairy with plasma urate, in a cross-sectional study. PLoS One 2012, 7(6):e38123.
95. Garrel D.R., Verdy M., PetitClerc C., et al. Milk- and soy-protein ingestion: acute effect on serum uric acid concentration. Am J Clin Nutr 1991, 53(3):665-669.
96. Ryu K.A., Kang H.H., Kim S.Y., et al. Comparison of nutrient intake and diet quality between hyperuricemia subjects and controls in Korea. Clin Nutr Res 2014, 3(1):56-63.
97. Dalbeth N., Wong S., Gamble G.D., et al. Acute effect of milk on serum urate concentrations: a randomised controlled crossover trial. Ann Rheum Dis 2010, 69(9):1677-1682.
98. Dalbeth N., Gracey E., Pool B., et al. Identification of dairy fractions with anti-inflammatory properties in models of acute gout. Ann Rheum Dis 2010, 69(4):766-769.
99. Dalbeth N., Ames R., Gamble G.D., et al. Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial. Ann Rheum Dis 2012, 71(6):929-934.
100. Kiyohara C., Kono S., Honjo S., et al. Inverse association between coffee drinking and serum uric acid concentrations in middle-aged Japanese males. Br J Nutr 1999, 82(2):125-130.
101. Pham N.M., Yoshida D., Morita M., et al. The relation of coffee consumption to serum uric Acid in Japanese men and women aged 49-76 years. JNutr Metab 2010, 2010.
102. Choi H.K., Curhan G. Coffee, tea, and caffeine consumption and serum uric acid level: the third national health and nutrition examination survey. Arthritis Rheum 2007, 57(5):816-821.
103. Choi H.K., Willett W., Curhan G. Coffee consumption and risk of incident gout in men: a prospective study. Arthritis Rheum 2007, 56(6):2049-2055.
104. Choi H.K., Curhan G. Coffee consumption and risk of incident gout in women: the Nurses' Health Study. Am J Clin Nutr 2010, 92(4):922-927.
105. Stein H.B., Hasan A., Fox I.H. Ascorbic acid-induced uricosuria. A consequency of megavitamin therapy. Ann Intern Med 1976, 84(4):385-388.
106. Huang H.Y., Appel L.J., Choi M.J., et al. The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial. Arthritis Rheum 2005, 52(6):1843-1847.
107. Gao X., Curhan G., Forman J.P., et al. Vitamin C intake and serum uric acid concentration in men. JRheumatol 2008, 35(9):1853-1858.
108. Choi H.K., Gao X., Curhan G. Vitamin C intake and the risk of gout in men: a prospective study. Arch Intern Med 2009, 169(5):502-507.
109. Juraschek S.P., Miller E.R., Gelber A.C. Effect of oral vitamin C supplementation on serum uric acid: a meta-analysis of randomized controlled trials. Arthritis Care Res (Hoboken) 2011, 63(9):1295-1306.
110. Jacob R.A., Spinozzi G.M., Simon V.A., et al. Consumption of cherries lowers plasma urate in healthy women. JNutr 2003, 133(6):1826-1829.
111. Zhang Y., Neogi T., Chen C., et al. Cherry consumption and decreased risk of recurrent gout attacks. Arthritis Rheum 2012, 64(12):4004-4011.
112. Schlesinger N., Schlesinger M. Previously reported prior studies of cherry juice concentrate for gout flare prophylaxis: comment on the article by Zhang etal. Arthritis Rheum 2013, 65(4):1135-1136.
113. Williams P.T. Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men. Am J Clin Nutr 2008, 87(5):1480-1487.
114. Choi H.K., Atkinson K., Karlson E.W., et al. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005, 165(7):742-748.
115. Dalbeth N., Chen P., White M., et al. Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes: a prospective longitudinal study. Ann Rheum Dis 2014, 73(5):797-802.
116. Antozzi P., Soto F., Arias F., et al. Development of acute gouty attack in the morbidly obese population after bariatric surgery. Obes Surg 2005, 15(3):405-407.
117. Dalbeth N., Pool B., Yip S., et al. Effect of bariatric surgery on the inflammatory response to monosodium urate crystals: a prospective study. Ann Rheum Dis 2013, 72(9):1583-1584.
118. Hanna B.E., Hamed J.M., Touhala L.M. Serum uric Acid in smokers. Oman Med J 2008, 23(4):269-274.
119. Tsuchiya M., Asada A., Kasahara E., et al. Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma. Circulation 2002, 105(10):1155-1157.
120. Harrold L.R., Yood R.A., Mikuls T.R., et al. Sex differences in gout epidemiology: evaluation and treatment. Ann Rheum Dis 2006, 65(10):1368-1372.
121. Shima Y., Teruya K., Ohta H. Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese. Life Sci 2006, 79(23):2234-2237.
122. Jang W.C., Nam Y.H., Park S.M., et al. T6092C polymorphism of SLC22A12 gene is associated with serum uric acid concentrations in Korean male subjects. Clin Chim Acta 2008, 398(1-2):140-144.
123. Guan M., Zhang J., Chen Y., et al. High-resolution melting analysis for the rapid detection of an intronic single nucleotide polymorphism in SLC22A12 in male patients with primary gout in China. Scand J Rheumatol 2009, 38(4):276-281.
124. Tu H.P., Chen C.J., Lee C.H., et al. The SLC22A12 gene is associated with gout in Han Chinese and Solomon Islanders. Ann Rheum Dis 2010, 69(6):1252-1254.
125. Li S., Sanna S., Maschio A., et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet 2007, 3(11):e194.
126. McArdle P.F., Parsa A., Chang Y.P., et al. Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order amish. Arthritis Rheum 2008, 58(9):2874-2881.
127. Stark K., Reinhard W., Neureuther K., et al. Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study. PLoS One 2008, 3(4):e1948.
128. Hollis-Moffatt J.E., Xu X., Dalbeth N., et al. Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Maori, Pacific Island, and Caucasian case-control sample sets. Arthritis Rheum 2009, 60(11):3485-3492.
129. Tu H.P., Chen C.J., Tovosia S., et al. Associations of a non-synonymous variant in SLC2A9 with gouty arthritis and uric acid levels in Han Chinese subjects and Solomon Islanders. Ann Rheum Dis 2010, 69(5):887-890.
130. Urano W., Taniguchi A., Anzai N., et al. Association between GLUT9 and gout in Japanese men. Ann Rheum Dis 2010, 69(5):932-933.
131. Yang Q., Kottgen A., Dehghan A., et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet 2010, 3(6):523-530.
132. Charles B.A., Shriner D., Doumatey A., et al. Agenome-wide association study of serum uric acid in African Americans. BMC Med Genomics 2011, 4:17.
133. Hamajima N., Okada R., Kawai S., et al. Significant association of serum uric acid levels with SLC2A9 rs11722228 among a Japanese population. Mol Genet Metab 2011, 103(4):378-382.
134. Sulem P., Gudbjartsson D.F., Walters G.B., et al. Identification of low-frequency variants associated with gout and serum uric acid levels. Nat Genet 2011, 43(11):1127-1130.
135. Li C., Chu N., Wang B., et al. Polymorphisms in the presumptive promoter region of the SLC2A9 gene are associated with gout in a Chinese male population. PLoS One 2012, 7(2):e24561.
136. Voruganti V.S., Kent J.W., Debnath S., et al. Genome-wide association analysis confirms and extends the association of SLC2A9 with serum uric acid levels to Mexican Americans. Front Genet 2013, 4:279.
137. Voruganti V.S., Franceschini N., Haack K., et al. Replication of the effect of SLC2A9 genetic variation on serum uric acid levels in American Indians. Eur J Hum Genet 2014, 22(7):938-943.
138. Phipps-Green A.J., Hollis-Moffatt J.E., Dalbeth N., et al. Astrong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Maori, case and control sample sets. Hum Mol Genet 2010, 19(24):4813-4819.
139. Wang B., Miao Z., Liu S., et al. Genetic analysis of ABCG2 gene C421A polymorphism with gout disease in Chinese Han male population. Hum Genet 2010, 127(2):245-246.
140. Yamagishi K., Tanigawa T., Kitamura A., et al. The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people. Rheumatology (Oxford) 2010, 49(8):1461-1465.
141. Matsuo H., Takada T., Ichida K., et al. Identification of ABCG2 dysfunction as a major factor contributing to gout. Nucleosides Nucleotides Nucleic Acids 2011, 30(12):1098-1104.
142. Matsuo H., Takada T., Ichida K., et al. ABCG2/BCRP dysfunction as a major cause of gout. Nucleosides Nucleotides Nucleic Acids 2011, 30(12):1117-1128.
143. Eastmond C.J., Garton M., Robins S., et al. The effects of alcoholic beverages on urate metabolism in gout sufferers. Br J Rheumatol 1995, 34(8):756-759.
144. van der Gaag M.S., van den Berg R., van den Berg H., et al. Moderate consumption of beer, red wine and spirits has counteracting effects on plasma antioxidants in middle-aged men. Eur J Clin Nutr 2000, 54(7):586-591.
145. Zhang Y., Woods R., Chaisson C.E., et al. Alcohol consumption as a trigger of recurrent gout attacks. Am J Med 2006, 119(9):800.e13-800.e18.
146. Neogi T., Chen C., Niu J., et al. Alcohol quantity and type on risk of recurrent gout attacks: an internet-based case-crossover study. Am J Med 2014, 127(4):311-318.